Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
Taro Pharmaceutical Industries Ltd. (TARO) had Return on Investments of 1.47% for the most recently reported fiscal year, ending 2023-03-31.
| Income Statement Financials | |
$572.95M |
|
$25.45M |
|
$304.63M |
|
$268.32M |
|
$555.24M |
|
$17.71M |
|
$20.50M |
|
$38.21M |
|
$38.21M |
|
$25.45M |
|
$25.45M |
|
$25.45M |
|
$25.45M |
|
$17.71M |
|
$58.01M |
|
37.59M |
|
37.59M |
|
$0.68 |
|
$0.68 |
|
| Balance Sheet Financials | |
$1.34B |
|
$190.14M |
|
$799.09M |
|
$2.14B |
|
$385.55M |
|
-- |
|
$19.11M |
|
$404.65M |
|
$1.73B |
|
$1.71B |
|
$1.73B |
|
37.59M |
|
| Cash Flow Statement Financials | |
$31.75M |
|
$-125.56M |
|
-- |
|
$251.13M |
|
$154.50M |
|
$-96.64M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.47 |
|
-- |
|
-- |
|
-- |
|
-- |
|
46.83% |
|
3.09% |
|
3.09% |
|
10.13% |
|
6.67% |
|
4.44% |
|
$14.17M |
|
-- |
|
-- |
|
-- |
|
0.27 |
|
1.34 |
|
2.21 |
|
165.30 |
|
1.47% |
|
1.48% |
|
1.19% |
|
|
Return on Investments |
1.47% |
$46.05 |
|
$0.38 |
|
$0.84 |
|